Home » Topics » Regulatory

Regulatory
RSS

Remicade recommended for approval in E.U. for treatment of rheumatoid arthritis

Feb. 24, 2000

Nastech's NDA for intranasal scopolamine not accepted for filing

Feb. 24, 2000

Pregabalin now claimed for renal colic-associated pain

Feb. 24, 2000

New antiepileptic Diastat available in Canada for ARS

Feb. 23, 2000

GABA analogues useful for insomnia

Feb. 22, 2000

Small patient study indicates potential of baclofen in treating alcoholism

Feb. 22, 2000

FDA approves first vaccine for prevention of invasive pneumococcal disease in infants and toddlers

Feb. 18, 2000

Pharmacyclics' texaphyrins now claimed for use in macrophage-mediated conditions

Feb. 17, 2000

Transmucosal clemastine under study at Nastech for motion sickness

Feb. 16, 2000

Bio-Technology General obtains first marketing approval worldwide for HBV vaccine

Feb. 15, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...